Track and Trace Systems Need Global Alignment, Regulators Urge
Executive Summary
International Coalition of Medicines Regulatory Authorities (ICMRA) wants regulators to think globally when designing and implementing track and trace systems so that counterfeit or substandard products identified in one jurisdiction can be tracked and halted at the borders of other countries. Existing systems have been designed with a national or regional focus only.
You may also be interested in...
EMA Maps Global Drug Supply Chain Regulatory Gaps For ICMRA
Gaps and overlaps in global and regional efforts to protect pharmaceutical supplies from intrusion of fake drugs, manufacturing quality problems and natural disasters are among the issues the European Medicines Agency has identified by mapping international initiatives for the International Coalition of Medicines Regulatory Authorities.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.